M. Petri, MD, MPH, Division of Rheumatology, Johns Hopkins University School of Medicine;
E. Barr, MPH, L.S. Magder, MPH, PhD, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
J Rheumatol. 2021 Feb;48(2):222-227. doi: 10.3899/jrheum.191094. Epub 2020 Apr 15.
The frequency of endstage renal disease (ESRD) from systemic lupus erythematosus (SLE) in the United States has not improved over the last few decades in large population datasets. Understanding the risk factors for renal failure in SLE could lead to earlier detection of lupus nephritis and potentially more effective treatments in those with markers of poor prognosis.
The Hopkins Lupus Cohort, comprising 2528 patients was used. One hundred fifty-one patients experienced renal failure after SLE diagnosis, defined as dialysis or renal transplant. We estimated the risk of renal failure in subgroups defined by demographics, laboratory tests, and the American College of Rheumatology/Systemic Lupus International Collaborating Clinics (ACR/SLICC) classification criteria satisfied within 1 year of SLE diagnosis.
The overall incidence of renal failure within 20 years of SLE diagnosis was 8.4%. The risk was much higher (20.0%) among those who experienced proteinuria within the first year of diagnosis. Demographic predictors included African American ethnicity [rate ratio (RR) 1.82, = 0.0012] and age ≥ 40 years at SLE diagnosis (RR 0.51 vs those with diagnosis at < 30 yrs of age, = 0.019). Among immunologic markers, low C3 was a strong predictor of renal failure (RR 2.00, = 0.0011).
Proteinuria within the first year of diagnosis of SLE is one of the most important predictors of ESRD. Our data also confirm African American ethnicity, younger age at SLE diagnosis, and low C3 as strong predictors of renal failure.
在美国,过去几十年中,系统性红斑狼疮(SLE)导致的终末期肾病(ESRD)的发病率并未改善。了解 SLE 患者发生肾衰竭的风险因素可能有助于更早地发现狼疮性肾炎,并为那些有预后不良标志物的患者提供更有效的治疗。
使用了包括 2528 例患者的霍普金斯狼疮队列。151 例患者在 SLE 诊断后出现肾衰竭,定义为透析或肾移植。我们根据人口统计学、实验室检查以及在 SLE 诊断后 1 年内满足的美国风湿病学会/系统性红斑狼疮国际合作诊所(ACR/SLICC)分类标准,在亚组中估计肾衰竭的风险。
在 SLE 诊断后 20 年内,肾衰竭的总体发生率为 8.4%。在诊断后第一年出现蛋白尿的患者中,风险更高(20.0%)。人口统计学预测因素包括非裔美国人种族(RR 1.82, = 0.0012)和 SLE 诊断时年龄≥40 岁(RR 0.51,与诊断年龄<30 岁的患者相比, = 0.019)。在免疫标志物中,C3 水平低是肾衰竭的强烈预测因素(RR 2.00, = 0.0011)。
SLE 诊断后第一年的蛋白尿是 ESRD 的最重要预测因素之一。我们的数据还证实,非裔美国人种族、SLE 诊断时年龄较小和 C3 水平低是肾衰竭的强烈预测因素。